We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
201
Kura Oncology
KURA
$882M
$1.56M 0.05%
83,266
-16,596
-17% -$313K
GYRE icon
202
Gyre Therapeutics
GYRE
$706M
$1.53M 0.05%
+49,678
New +$1.63M
REUN
203
CALL
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$1.4M 0.04%
+61,140
New +$1.54M
RCOR
204
DELISTED
Renovacor, Inc.
RCOR
$1.38M 0.04%
152,079
-1,881
-1% -$18.3K
ADPT icon
205
CALL
Adaptive Biotechnologies
ADPT
$4.02B
$1.36M 0.04%
+40,000
New +$1.45M
RPTX
206
CALL
DELISTED
Repare Therapeutics
RPTX
$1.31M 0.04%
+50,000
New +$1.62M
TVTX icon
207
Travere Therapeutics
TVTX
$5.86B
$1.3M 0.04%
53,790
-51,592
-49% -$948K
CYCN icon
208
Cyclerion Therapeutics
CYCN
$18.4M
$1.3M 0.04%
21,116
-4,258
-17% -$279K
ARNA
209
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.19M 0.04%
+20,000
New +$1.18M
NVRO
210
DELISTED
NEVRO CORP.
NVRO
$1.16M 0.04%
10,000
-20,000
-67% -$2.62M
ABGI
211
DELISTED
ABG Acquisition Corp. I
ABGI
$1.16M 0.04%
119,228
-123,542
-51% -$1.2M
GOSS icon
212
Gossamer Bio
GOSS
$86.8M
$1.13M 0.03%
90,077
-8,556
-9% -$78.8K
LOGC
213
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.12M 0.03%
245,492
-3,764
-2% -$16.6K
ABOS icon
214
Acumen Pharmaceuticals
ABOS
$181M
$1.11M 0.03%
+75,000
New +$1.25M
TNGX icon
215
Tango Therapeutics
TNGX
$4.31B
$1.1M 0.03%
84,762
-14,159
-14% -$170K
OBIO icon
216
Orchestra BioMed
OBIO
$266M
$1.05M 0.03%
106,302
-1,616
-1% -$16K
PHAT icon
217
Phathom Pharmaceuticals
PHAT
$742M
$1.05M 0.03%
32,575
-12,636
-28% -$420K
CRBU icon
218
Caribou Biosciences
CRBU
$169M
$1.04M 0.03%
+43,639
New +$1.07M
ARYE
219
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$988K 0.03%
+100,000
New +$993K
VINC
220
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$967K 0.03%
2,990
-7,712
-72% -$2.25M
VRDN icon
221
Viridian Therapeutics
VRDN
$2.59B
$956K 0.03%
+58,096
New +$852K
FHTX icon
222
Foghorn Therapeutics
FHTX
$394M
$949K 0.03%
+68,095
New +$754K
CLSD
223
CALL
DELISTED
Clearside Biomedical
CLSD
$939K 0.03%
+10,433
New +$921K
KDNY
224
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$928K 0.03%
72,698
-1,279
-2% -$16.8K
AVEO
225
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$912K 0.03%
147,574
+50,027
+51% +$299K
7 8
9
10 11

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.